Episode 93
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
Episode 93
-
Letto da:
-
Di:
A proposito di questo titolo
In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing the potential role of GLP-1 therapies in alcohol and substance use disorders, risk factors associated with long-term opioid prescribing, patient motivation and readiness to taper opioids for chronic pain, national trends in ADHD medication prescribing, and more!
- GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer Published in the Journal of Endocrine Society, October 2025
- A national cohort study of long-term opioid prescription and sociodemographic and health care-related risk factors Published in Communications Medicine, September 2025
- Patient Motivation to Reduce or Discontinue Opioids for Chronic Pain: Self-efficacy, Barriers, and Readiness to Change Published in the Clinical Journal of Pain, January 2024
- Population-Level Trends in Attention-Deficit/Hyperactivity Disorder Medication Prescribing Published in JAMA Network Open, December 2025
- Increased Avoidance Learning in Chronic Opioid Users Published in JAMA Pyschiatry, November 2025
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione